PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026BMC Immunology0 citationsOpen Access

The correlation between the systemic immune-inflammation index and relapse and metastasis in cervical squamous cell carcinoma patients over 50 years and older

View Full Paper
YJYanjun JiaoYHYang HeBZBinyan Zhao

Key Points

  • To investigate the relationship between systemic immune-inflammation index (SII) and cancer relapse and metastasis in patients over 50 with cervical squamous cell carcinoma (CSCC).
  • Analyzed levels of systemic immune-inflammation index (SII) in cervical squamous cell carcinoma patients aged 50 and older.
  • Monitored and recorded incidences of relapse and metastasis among these patients.
  • Higher systemic immune-inflammation index (SII) levels correlate with a significantly increased risk of cancer relapse.
  • Patients with elevated SII show a greater likelihood of metastasis, indicating poorer prognosis.

Abstract

Higher levels of SII are significantly associated with a higher risk of relapse and metastasis, indicating that SII may have important clinical value in the prognosis assessment of CSCC.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jiao et al. (2026) studied this question.

synapsesocial.com/papers/6980fcb6c1c9540dea80e834https://doi.org/10.1186/s12865-025-00791-8
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High M2-TAM Infiltration and STAT3/NF-κB Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer2024 · 13 citations
  2. 2Risk factors for the development of cervical cancer: analysis of the evidence2024 · 35 citations
  3. 3The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy2024 · 22 citations
  4. 4Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses2005 · 107 citations
  5. 5NCCN Guidelines® Insights: Cervical Cancer, Version 1.20242023 · 383 citations